Biomarkers, breast density and risk reduction perspectives in BRCA carriers.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 02 Aug 2018
At a glance
- Drugs Deslorelin (Primary) ; Estradiol (Primary) ; Testosterone (Primary)
- Indications Breast cancer
- Focus Biomarker; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 25 Jul 2018 Planned End Date changed from 1 Sep 2018 to 1 Sep 2019.
- 25 Jul 2018 Planned primary completion date changed from 1 Sep 2018 to 1 Sep 2019.